Thirdly, this study lacks parameters or clinical tests, with which we could seek further the relationships between AM levels and low-grade inflammation associated with obesity or alterations of body fat distribution (6, 11), such as C-reactive protein and magnetic resonance imaging, and these points need to be clarified in future studies. The gene discussed is CRP; the disease is obesity disorder.